Showing results (1511-1520 of 1,616) with videos related to
Sort By:
Pageof 162
Journal of Inherited Metabolic Disease|June 10, 2019
Expanding the genetic and phenotypic spectrum of branched-chain amino acid transferase 2 deficiencyIna Knerr, Roberto Colombo, Jill Urquhart, et al.JCI Insight|September 22, 2022
Loss of TRPV2-mediated blood flow autoregulation recapitulates diabetic retinopathy in ratsMichael O'Hare, Gema Esquiva, Mary K McGahon, et al.Eclinicalmedicine|July 21, 2025
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trialJunwen Zhou, Claire Williams, Natalie Staplin, et al.Journal of Medicinal Chemistry|November 27, 2023
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)Young Chen, Brandon Whitefield, Erin Nevius, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph)Lindsay M Morton, Patricia Hartge, Theodore R Holford, et al.Genome Medicine|November 7, 2023
Building blocks for better biorepositories in AfricaTalishiea Croxton, Emmanuel Jonathan, Kareemah Suleiman, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2024
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trialParminder K Judge, Katherine R Tuttle, Natalie Staplin, et al.The Lancet. Oncology|July 5, 2005
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysisLindsay M Morton, Tongzhang Zheng, Theodore R Holford, et al.Hepatology (Baltimore, Md.)|December 4, 2024
Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study designM Alan Brookhart, Tracy J Mayne, Charles Coombs, et al.Plos One|November 1, 2011
Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer riskTodd M Gibson, Paul Brennan, Summer Han, et al.Pageof 162